Biochemical and functional quality assessment of platelet concentrates

  • Nebojša Vacić Clinical Center Niš, Clinic for Haematology, Niš, Serbia
  • Ana Antić Blood Transfusion Institute Niš, Niš, Serbia
  • Zoran Stanojković Blood Transfusion Institute Niš, Niš, Serbia
  • Miodrag Vučić Clinical Center Niš, Clinic for Haematology, Clinic for Vascular Surgery, Niš, Serbia
  • Milan Lazarević Clinical Center Niš, Department of Cardiac Surgery, Niš, Serbia
Keywords: blood platelets, reference standards, blood chemical analysis, platelet aggregation, platelet count

Abstract


Background/Aim. Preparation of platelet concentrate (PC) from a unit of whole blood is a method dependent on a number of factors, which alone or together, can have a significant impact on the quality of the final product. Qual­ity of PCs is determined with criteria defined in the Guide to the preparation, use and quality assurance of the Council of European Committee for Blood Transfusion. The aim of the study was to analyze the quality of PCs prepared from buffy coat (BC) and to allocate the factors of improvement and standardization of the quality of PCs. Methods. The study included a total of 80 PCs prepared from BC accord­ing to the standard procedure in the Blood Transfusion In­stitute Niš. The quality of PCs was determined according to the product volume and laboratory testing on the first (PC1), the third (PC3) and the fifth day (PC5) of the PC stor­age. The following parameters were determined: platelets, residual erythrocytes and leukocytes count, gas analysis [partial pressure of oxygen, carbon dioxide (pO2, pCO2)], pH, sterility and platelet aggregation triggered by using 3.2, 6.4 and 9.6 μg collagen/mL (impedance aggregometry). Re­sults. There were significantly lower platelet count, pO2, pCO2 and pH in the PC3 and PC5 samples (p < 0.001). Ex­cept for the fulfillment of the criteria for platelet count, all the other quality parameters were in accordance with rec­ommended criteria. Platelet aggregation for all the concen­trations of collagen showed a decrease during the storage period, with statistically significant differences for PC3 and PC5 as compared to PC1 (p < 0.01). There was statistically significant decrease in activity of PCs triggered with higher concentrations of collagen (6.4 and 9.6 μg collagen/mL) in comparison with lower concentration of collagen (3.2 μg collagen/mL). Conclusion. Platelet count, evaluated bio­chemical parameters and the platelet function were signifi­cantly changed during the storage period. In order to im­prove the quality of PCs it is important to store the prod­ucts under proper conditions, change the type of plastic bag for PC storage and use platelet additive solutions (PAS) in­stead of plasma.

References

Balint B, Todorović M. From hematopoiesis to clinical applica-tion of haemoproduct. In: Balint B, Trkluljic M, Todorovic M. Basic principles of chemotherapy. Belgrade: Institute of Trans-fusion Medicine, Military Medical Academy; 2010. p.126–31. (Serbian)

Tynngård N. Preparation, storage and quality control of plate-let concentrates. Transfus Apher Sci 2009; 41(2): 97–104.

Hess JR. Conventional blood banking and blood component storage regulation: opportunities for improvement. Blood Transfus 2010; 8 (Suppl 3): s9–s15.

Stanojković Z, Antić A, Stanojević G, Stanojković M, Jelić M. Cur-rent principles of preparation and improvement of storage conditions of platelet concentrates. Bilt Transfuziol 2012; 58(1): 13–9. (Serbian)

Singh RP, Marwaha N, Malhotra P, Dash S. Quality assessment of platelet concentrates prepared by platelet rich plasma-platelet concentrate, buffy coat poor-platelet concentrate (BC-PC) and apheresis-PC methods. Asian J Transfus Sci 2009; 3(2): 86–94.

Antić A, Stanojković Z, Jelić M, Stanojković M. Quality assessment of platelet concentrates prepared using top&bottom blood bags. Bilt Transfuziol 2013; 59(1–2): 9–13. (Serbian)

Mokhtar MB, Hashim HB, Joshi SR. Assessment of quality of platelets preserved in plasma and platelet additive solution: A Malaysian experience. Asian J Transfus Sci 2016; 10(1): 84–7.

Council of Europe. Guide to preparation, use and quality assur-ance of blood components.19th ed. Strasbourg, France: Eu-ropean Directorate for the Quality of Medicines & HealthCare; 2017.

Paniccia R, Priora R, Liotta AA, Abbate R. Platelet function tests: a comparative review. Vasc Health Risk Manag 2015; 11: 133–48.

Panzer S, Jilma P. Methods for testing platelet function for transfusion medicine. Vox Sang 2011; 101(1): 1–9.

Kehrel E, Brodde FM. State of the Art in Platelet Function Testing.Transfus Med Hemother 2013; 40(2): 73–86.

Gulliksson H. Platelets from platelet-rich-plasma versus buffy-coat-derived platelets: what is the difference? Rev Brasil He-matol Hemoter 2012; 34(2): 76–7.

Vucetić D, Balint B, Taseski J, Mandić-Radić S, Regović V. Bio-chemical changes in thrombocyte concentrates stored for 5 day. Vojnosanit Pregl 2000; 57(5): 29–36. (in Serbian)

Rinalducci S, Zolla L. Biochemistry of storage lesions of red cell and platelet concentrates: A continuous fight implying oxida-tive/nitrosative/phosphorylative stress and signaling. Transfus Apher Sci 2015; 52(3): 262–9.

Kshitija M, Ravneet K. Platelet storage lesion: An update. Asian J Transfus Sci 2015; 9(1): 1–3.

Balint B, Todorović M. From haematopoesis to clinical use of haemoproducts. In: Balint B, editor. The basic principles of haemotherapy. Belgrade: Čigoja; 2010. p. 128-31. (Serbian)

Stanojković Z, Antić A, Stanojković M. Rational use of platelet transfusion. Proceedings of the Fifth Annual Spring Scientific Symposium in Anaesthesiology and Intensive Care Unit. Niš: University of Niš, Faculty of Medicine; 2013. p. 206–11.

Mathai J. Problem of bacterial contamination in platelet con-centrates. Transfus Apher Sci 2009; 41(2): 139–44.

Doescher A, Müller TH. Noninvasive pH Monitoring in Platelet Concentrates. Transfus Med Hemother 2013; 40(2): 88–92.

Riugwald I, Zimmermann R, Strasser E, Weiss D, Eckstein R. Masuring the pH of platelet concentrates. Transfusion 2006; 46(5): 870–1.

Gupta A, Chandra T, Kumar A. Evaluation of random donor platelets at different temperatures for an extended shelf life. Biomed Res 2010; 21(4): 433–6.

Coêlho MJ, Monteiro Tde C, Vasquez FG, Silva KL, Dos Santos KS, de Oliveira VM, et al. Platelet aggregation and quality con-trol of platelet concentrates produced in the Amazon Blood Bank. Rev Bras Hematol Hemoter 2011; 33(2): 110–4.

Neiva T, Machado M, Hoehn M, Hermes E, Vituri C, Ferreira J, et al. Evaluation of platelet aggregation in platelet concen-trates: storage implications. Rev Brasil Hematol Hemoter 2003; 25(4): 207–12.

Shabani NR, Baqir H. Quality Assessment of Platelet Concen-trates Prepared after Whole Blood Overnight Storage. J Med Bioeng 2014; 3(2): 87–92.

Mallhi RS, Kumar S, Philip J. A Comparative Assessment of Quality of Platelet Concentrates Prepared by Buffy Coat Poor Platelet Concentrate Method and Apheresis Derived Platelet Concentrate Method. Indian J Hematol Blood Transfus 2015; 31(4): 453–9.

Stanojković Z, Antić A, Stanojković M, Jelić M. The use of addi-tive solution for preparation and storage of platelets. Bilt Transfuziol 2014; 60(1–2): 43–5.

van der Meer PF. PAS or plasma for storage of platelets? A concise review. Transfus Med 2016; 26(5): 339–42.

Gulliksson H. Platelet storage media. Vox Sang 2014; 107(3): 205–12.

Rebulla P, Vaglio S, Beccaria F, Bonfichi M, Carella A, Chiurazzi F, et al. Clinical effectiveness of platelets in additive solution treated with two commercial pathogen-reduction technolo-gies. Transfusion 2017; 57(5): 1171–83.

Published
2021/08/19
Section
Original Paper